FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
IPO Status: Listed [16th Dec 2021 to 20th Dec 2021]
Supriya Lifescience IPO of Rs 700 Cr is opening soon to list on the BSE and NSE. The IPO opens for subscription from 16 to 20 Dec, 2021. The face value per share is Rs. 2 and the IPO price band is Rs. 265-274 and the lot size is 54 shares. Stay updated with us to know more about the Supriya Lifescience IPO issue size, minimum order amount, business overview, company financials, live subscription, grey market premium (GMP), allotment status, and more.
IPO Issue Opening Date: | 16th Dec 2021 |
IPO Issue Closing Date: | 20th Dec 2021 |
IPO Issue Price: | ₹265-274 Per Share |
DRHP: | Download DRHP |
RHP: | Download RHP |
Anchor List: | Download Anchor List |
IPO Listing At: | BSE, NSE |
Retail Quota: | 10 |
IPO Issue Type: | Book Build Issue |
IPO Issue Size: | ₹700 Cr |
Offer for Sale: | ₹500 Cr |
Fresh Issue: | ₹200 Cr |
Face Value: | ₹2 Per Equity Share |
Promoter Holding Pre IPO: | 99.26 |
Promoter Holding Post IPO: | 67.59 |
Allotment Status: | Allotment Status |
BSE Code: | 543434 |
NSE Code: | SUPRIYA |
Get important updates regarding Supriya Lifescience IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
IPO Activity | Date |
---|---|
Basis of Allotment Date* | 23rd Dec 2021 |
Refunds Initiation* | 24th Dec 2021 |
Credit of Shares to Demat* | 27th Dec 2021 |
IPO Listing Date* | 28th Dec 2021 |
* - Tentative Dates
IPO Activity | Date |
---|---|
Issue Price | ₹265-274 |
Market Lot: | 54 Shares |
1 Lot Amount: | ₹14796 |
Min Small HNI Lots(2-10 Lakh): | 756 shares (14 lots) |
Min Big HNI Lots(10+ Lakh): |
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Expected Listing Gain | Last Updated |
---|---|---|---|---|---|
28-12-2021 | 274 | 130 | -- | ₹404 (47.45%) | 28-Dec-2021 8:52 |
Zerodha Trade@20
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Supriya Lifescience Limited is one of the biggest manufacturers and suppliers of active pharmaceutical ingredients (API). The company has a manufacturing facility located in Parshuram Lote, Maharashtra. The manufacturing unit has approval from major export countries for API supplies which include USFDA, EDQM, and EUGMP from AIFA - Italy, TGA-Australia, BfArM-Germany, KFDA-Korea, PMDA-Japan, SFDA- China, COFEPRIS - Mexico, etc. The company also has a DSIR approved R&D facility in Parshuram Lote, MH with a team of 16 scientists. Supriya Lifescience has a presence in domestic as well as international markets. At present, the company is exporting products in 78 countries.
Incorporation | Sector | IPO Issue Size | Website |
1987 | Pharmaceuticals | ₹700 Cr | https://supriyalifescience.dnsracks.com/ |
The IPO aims to raise funds for the following purposes;
The table below is live update of IPO bidding details from NSE and BSE.
Day | QIB | NII | RII | Total | |
---|---|---|---|---|---|
# of Shares Offered | 7,924,527 (54.55%) | 3,962,263 (27.27%) | 2,641,509 (18.18%) | 14,528,299 | |
1 | 16th Dec 2021 17:02 | 0.00x | 0.66x | 11.84x | 2.33x |
2 | 17th Dec 2021 17:02 | 0.53x | 2.90x | 25.38x | 5.69x |
3 | 18th Dec 2021 09:18 | 0.53x | 2.90x | 25.38x | 5.69x |
4 | 20th Dec 2021 19:54 | 31.83x | 161.22x | 56.01x | 71.51x |
Supriya Lifescience Financials (₹ in Cr) | 31-Sep-2021 | 31-Mar-2021 | 31-Mar-2020 | 31-Mar-2019 |
---|---|---|---|---|
Total Assets | ₹504.10 | ₹445.82 | ₹336.43 | ₹253.06 |
Total Income | ₹230.06 | ₹396.22 | ₹322.71 | ₹285.86 |
Net Profit/Loss | ₹66.00 | ₹123.83 | ₹73.38 | ₹39.42 |
Last Updated on 05-Jan-2022 10:39:57